ftypavifavifmif1miafumeta!hdlrpictpitmFilocD@= biinfinfeav01infeExif*infemimeapplication/rdf+xmljiprpKipcocolrnclx av1C ispepixiipma(irefcdsccdsc'mdat b864 2%De8R)Є/ "8:{ 8LRw^taaϦXoo g3!=op!9|Rk 䑍'Ezj.6%_%\wt^ݙFGV.ˡ8-V5,"׏I@(.dGoCN!0۲:hD0=9b(o&@'R:Ϧ#A vttKo Bþ™J'׌}#)? 2Q@Y]fD<Ȓ'wЎ}r ph<||;t`BDIq  [){LSO;፤n])T=ot Ƚ@9R/%vFgz&Ք>;/,#XҊyk1l"K|2'.u!7^z=k,_X1$dƹL ]@J䡒k@ DqC?lZ * BǹhY5(No?ƙJܛN$(bN<|$`>Rҝr1 !\- %m_5*y_oO+Iu5@/cDk8wiY)`6!3\;zJGPˆa|D ^v`c}Vbm:lPAT XBWv It943:l0۔%S h?2ZN?A"+6H]n[y$j2aGW!B{Yr%i8wREN\"#e F[E䏮wQ]Xmʔ.y#]GФEu^γ ]B@ Ӄt 5^B.7^\թnګ˸t z4ykmK0E%'[ ΓI٪9P,?w 2GDJ\Ln\BU[J}2`/& [t㬙Y5;ug5Q,Z3# Y"}@l.0²ħ #uOsdq~Z?DS)9붗gKƗ>0VMfA&{1Gf>KOF@_CFlS+>UaH+3V[Ņ] v`WX{[;|aO뺝^ 9>q 5!cɯհ ^\vzd(i\$wUW}}[k F 97oo5 TZaTeV~iyz߯N,] Cb5>VChLo"izb.}M%0G`nCYcJ))?%o_(HC4=,h-"s2jKvgX6 pm؄}7B/Ћ 8ս~ht7?:.W Ah=|sÁ[#Ë@|*7V+I. mWi 5nRYEz7 !;vFZی;ݓ+a{8< %E0AGX^hO k>/BDZlEkJEv,2%t:\:<,m~ȼk{BPK,Э%ysRv:UquV-]+׎):;T*apBgAU܂b-]Pɪ`QeDٺrsocMvȠIw?)W͂J}rm2l(,uJ@D~P7q6,)c 3QRE}ADXkЭq}[D+Ǟ|gnc) sh)s}+X֤*16sDMSц~_QPb:xϑz!4U]vál6JMpֲݶsZV3%fw/ǜ.T.AY~va>ϸtδ'/ p((:.au Q a!?-Dǝ𿇭}u?XIX8btLȴuRDzeqjTng8e,dKq^BaTG X)r%E'@ 9ukQ X8,2J8 fƦPH).9E# I{u举sJ''Un(ELځ_(}5"ǬPiEǔm$m7o0Pe͵(ml$"\z@`P<얥iD >,S)6[A;$VR4u\Q4,ZG7 $d6w!ک+{V`U" lh|.EYa#OSzYE ˧qHȃyWa5.=doPICq4ZSzfOz?U4-dq%jI*q'DHrFckqq-ʰN}7Z}fq96.l*6䮵'@|)Vsdi mNȤ]Gns3a?C^Z˓i~1n«ZK2<<=g5KC"hHOs?%+WOwS¶ݶ fd 4*'qy ]8&{|)H^:"d- hrrH45Jlxѷ=\f7M9M)ѲtZ<:k1#V3,xOaM%{'(^s [d(6`({L$ad(şQ03h LXf^(>i9;-|4$e d^$[U%_l;8!쟸ݯ;Mˈ;Ǔ5G6e FiL>!G6`L2$>2DYej# S࠽9P<7ȣ*tLlXs:hmȈT˷R#z=$^ 3Dv,ް Ź;6+ m6rRԉVlJ37Yh]^Z2qc;Az$c?<"gT}(\}+TPhM5B*x?u?[,izzHlmuh5U_<`1h!+/[;u]MG~1)3!wXnX̀6DҀq;xů`sly/ %ĞJyEgMaX 5#oD4B ؓsNsrj+PJm1 UwkwgZ(J=w)\ ĻlE H>j9@UAU lKo$*E:n ޅt`ë9/UnY ON ,CnOӤ ωL gGAJpYGZiiz On0 \ qj̹OΫ'Fv%\)hKVǐ͙^ ֪Q 7{s F2̭kwآ)D}9ӆAȵ%ݍSQ2ʹVnp elwMkii.AfTWWm A (hN~p>:HU27B G}zoOO:meݳP-ϕoRrz\9VĽKɮ Jč<&C9 ֧#NsTF<]8y0rz<Ims^8dܻJm]aۯ@]'*G& !/4 ab4djjFWh"W~S6ufA tJ)f-)e(Oi0dVm O-C6]3/(?GKRZ|3Lu"䞫t &JUUcuCuVKߵ+4lҘ0ՎCSPAԓdf?:ݻ8?Ms8>rM\:J?VL10z3ig͞~23Yx`OKW 2w>IR5JRnx[Veï{T3ѓɨլRQ̊R +W eMYg0GNBY|AW[xҕ-f,Ԟ\P5\H,͏X9'}v%~3"$pm@#LogʕdufAx#2_[9סYeEi1ExifMM*(;GFGIci..4<.P Clopitab-A 150 Capsule``Jaiswal Pharma;Pharma Bag02100100 vClopitab-A 150 CapsuleClopitab-A 150 CapsuleJaiswal Pharma;Pharma BagClopitab-A 150 Capsule;Clopitab-A 150 Capsule Uses;Clopitab-A 150 Capsule Dosage;Clopitab-A 150 Capsule Price;Clopitab-A 150 Capsule for Heart;Clopitab-A 150 Capsule Benefits;Clopitab-A 150 Capsule Side Effects;Clopitab-A 150 Capsule Composition;Clopitab-A 150 Capsule Manufacturer;Clopitab-A 150 Capsule Review;Buy Clopitab-A 150 Capsule;Clopitab-A 150 Capsule for Blood Pressure;Clopitab-A 150 Capsule WholesaleClopitab-A 150 Capsule 2025-01-17 f0a02808-01d0-4a16-835f-042fbc755efb 525265914179580 2 Clopitab-A 150 Capsule Clopitab-A 150 Capsule Jaiswal PharmaPharma Bag Clopitab-A 150 CapsuleClopitab-A 150 Capsule UsesClopitab-A 150 Capsule DosageClopitab-A 150 Capsule PriceClopitab-A 150 Capsule for HeartClopitab-A 150 Capsule BenefitsClopitab-A 150 Capsule Side EffectsClopitab-A 150 Capsule CompositionClopitab-A 150 Capsule ManufacturerClopitab-A 150 Capsule ReviewBuy Clopitab-A 150 CapsuleClopitab-A 150 Capsule for Blood PressureClopitab-A 150 Capsule Wholesale Jaiswal Pharma Canva (Renderer) doc=DAGa3JB-Mxc user=UAGHzo59KHI 5 99Clopitab-A 150 CapsuleClopitab-A 150 Capsule UsesClopitab-A 150 Capsule DosageClopitab-A 150 Capsule PriceClopitab-A 150 Capsule for HeartClopitab-A 150 Capsule BenefitsClopitab-A 150 Capsule Side EffectsClopitab-A 150 Capsule CompositionClopitab-A 150 Capsule ManufacturerClopitab-A 150 Capsule ReviewBuy Clopitab-A 150 CapsuleClopitab-A 150 Capsule for Blood PressureClopitab-A 150 Capsule Wholesale